Points of View
More Security and Risk Research
Big Pharma Must Invest in Distributed Ledger Technologies to Secure Their Supply Chains
The pharmaceutical industry has a huge issue on their hands because, according to the Worldwide Health Organization, sketchy drug provenance processes and systems have fueled a reality where “1 in 10 medical products in developing countries are substandard or falsified.” We’ve already discussed the solutions that blockchain disruptors are bringing to the drug provenance market; in this piece, we re-examine the vital work currently undertaken by the MediLedger project and the new kid on the block(chain), Chronicled. These innovative companies must be the starting shot for greater investment in blockchain solutions from big pharma companies looking to secure their supply chains.
Sign in or register an account to access HFS' Content
Create an account